Down-regulation of BMPR1B expression was recently reported in malignancies such as epithelial ovarian cancer [27], gliomas [50], and breast cancer [36], correlating with poor prognosis in such patients. The gene discussed is BMPR1B; the disease is ovarian carcinoma.